Lucid Diagnostics (LUCD) Other financing activities (2020 - 2026)
Lucid Diagnostics (LUCD) posted Other financing activities of $210000.0 for Q1 2026, down 18.29% on a QoQ basis from $257000.0 in Q4 2025, and up 6900.0% year-over-year from $3000.0 in Q1 2025.
Lucid Diagnostics (LUCD) Other financing activities (2020 - 2026) Analysis & Trends
Lucid Diagnostics' Other financing activities history runs 5 years deep, the most recent figure standing at $210000.0 for Q1 2026.
- Quarterly Other financing activities rose 6900.0% year-over-year to $210000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $480000.0 (up 5.96% YoY) and the FY2025 annual result came in at $272000.0, down 39.15% from the prior year.
- Other financing activities was $210000.0 for Q1 2026 at Lucid Diagnostics, down from $257000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $501000.0 in Q2 2022 and bottomed at $1000.0 in Q4 2022.
- A 4-year average of $183000.0 and a median of $159000.0 in 2022 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2025 — Other financing activities sank 99.15% — and 2026, when it jumped 6900.0%.
- Lucid Diagnostics' Other financing activities stood at $1000.0 in 2022, then surged by 44200.0% to $443000.0 in 2024, then plunged by 41.99% to $257000.0 in 2025, then retreated by 18.29% to $210000.0 in 2026.
- Business Quant data shows LUCD's Other financing activities at $210000.0 in Q1 2026, $257000.0 in Q4 2025, and $131000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Lucid Diagnostics | 133.09 Mn | 105.22 Mn | -325,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 210,000.00 |
| Mar 31, 2026 | 210,000.00 |
| Dec 31, 2025 | 257,000.00 |
| Dec 31, 2025 | 257,000.00 |
| Sep 30, 2025 | 131,000.00 |
| Sep 30, 2025 | 131,000.00 |
| Jun 30, 2025 | 10,000.00 |
| Jun 30, 2025 | 10,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | 443,000.00 |
| Dec 31, 2024 | 443,000.00 |
| Sep 30, 2024 | 94,000.00 |
| Sep 30, 2024 | 94,000.00 |
| Mar 31, 2024 | 353,000.00 |
| Mar 31, 2024 | 353,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Sep 30, 2022 | 6,000.00 |
| Sep 30, 2022 | 6,000.00 |